期刊文献+

严重脓毒症患者血清血管内皮生长因子的临床研究 被引量:3

A clinical study of the serum vascular endothelial growth factor in patients with severe sepsis
原文传递
导出
摘要 目的检测严重脓毒症患者血清血管内皮生长因子(VEGF)水平的动态变化,探讨VEGF与急性生理学与慢性健康状况评分系统Ⅱ(APACHEⅡ)评分及相关临床参数的关系。方法采用前瞻性随机对照研究,选择2006年7月-2007年10月本院重症监护病房(ICu)收治的29例严重脓毒症患者,检测发病后1、3、7d血小板计数(PLT)、白蛋白(Alb)水平,并计算APACHEI评分;采用酶联免疫吸附法(ELISA)检测血清VEGF水平,并按患者生存与死亡分为两组,比较两组的异同。以同期31例健康体检者作为健康对照组。结果健康对照组VEGF水平为(78.77±8.15)ng/L;生存组16例患者随时间延长VEGF水平逐渐下降(F=40.32,P〈0.01),7d时接近健康对照组(P〉0.05);死亡组13例患者VEGF水平3d下降,7d又上升(F=29.61,P〈0.01)。VEGF水平与APACHEⅡ评分呈显著正相关(r=0.510,P=0.000),与PLT呈显著负相关(r=-0.221,P=0.046),与A1b未显示相关性(r=-0.029,P=0.789)。结论严重脓毒症患者VEGF水平在发病早期明显升高,随病程进展生存组VEGF水平逐渐下降,死亡组下降不明显,VEGF在一定程度上反映脓毒症病情严重程度。 Objective To examine the dynamic changes in serum vascular endothelial growth factor (VEGF) levels in patients with severe sepsis, and to investigate its relationship with acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) score and some clinical parameters of patients. Methods Using prospective, randomly control study design, 29 patients with severe sepsis admitted to the intensive care unit (ICU) of the Second Hospital of Tianjin Medical University from July 2006 to October 2007 were enrolled for study. Platelet (PLT) count and albumin (Alb) levels on the 1st, 3rd, 7th day were determined, and APACHE Ⅱ score was assessed. VEGF levels of severe sepsis patients and healthy control volunteers (31 cases) were measured by enzyme linked immunoabsorbant assay (ELISA). The patients were divided into two groups according to survival or death, and the differences between two groups were compared. Results The VEGF level in the health control group was (78. 77±8.15) ng/L. In 16 survivors, the VEGF levels gradually lowered along the course of the disease (F= 40. 32, P〈0. 01). There was no statistical difference between control group and survival group on the 7th day (P〈0.05). Thirteen patients died, and their VEGF levels lowered on the 3rd day, but elevated again on the 7th day (F=29.61, P〈0. 01). The VEGF levels showed obvious positive correlation with APACHE Ⅱ score (r= 0. 510, P = 0. 000), and negative correlation with PLT (r= 0. 221, P = 0. 046), and no relation with Alb levels (r= 0. 029, P=0. 789). Conclusion The VEGF levels are elevated at onset in severe sepsis patients. The VEGF levels lowered along with the course of the disease in survival group, but it lowers unconspicuously in death group. VEGF levels can reflect the severity of sepsis in certain degree.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2009年第3期172-174,共3页 Chinese Critical Care Medicine
基金 天津市医药卫生科技基金项目(07KZ83)
关键词 严重脓毒症 血管内皮生长因子 急性生理学与慢性健康状况评分系统Ⅱ评分 血小板计数 severe sepsis vascular endothelial growth factor acute physiology and chronic health evaluation I score platelet count
  • 相关文献

参考文献2

二级参考文献30

  • 1Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999; 5:487-491.
  • 2Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis.Semin Cancer Biol 1999; 9:211-220.
  • 3Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J1999; 13:9-22.
  • 4Linderholm B, Lindh B, Tavelin B, Grankvist K, HenrikssonR. p53 and vascular endothelial growth factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000; 89:51-62.
  • 5Toi M, Bando H, Ogawa T, Muta M, Hornig C, Weich HA.Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer. Int J Cancer 2002; 98:14-18.
  • 6Kumar H, Heer K, Lee PW, Duthie GS, MacDonald AW,Greenman J, Kerin MJ, Monson JR. Preoperative serum vascular endothelial growth factor can predict stage in colorectal tumor. Clin Cancer Res 1998; 4:1279-1285.
  • 7George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer:Clinical evidence of platelet scavenging? Clin Cancer Res2000; 6:3147-3152.
  • 8Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J,Joukov V, Orpana A, Ristimaki A, Heikinheimo M, JoensuuH, Alitalo K, Palotie A. A peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998; 80:171-175.
  • 9Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM,Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998; 275(3 Pt 2): H1054-1061.
  • 10Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 1998; 94- 395-404.

共引文献38

同被引文献48

  • 1邱海波,杨毅,刘松桥.《2004严重感染和感染性休克治疗指南》系列讲座(2) 严重感染和感染性休克的容量复苏和血管活性药物应用[J].中国危重病急救医学,2004,16(8):451-453. 被引量:110
  • 2武钧,毛恩强,李建芳,瞿颖,陈雪华,张明钧,汤耀卿.肝缺血/再灌注损伤时内皮祖细胞的变化[J].肝胆外科杂志,2006,14(3):228-231. 被引量:6
  • 3邱一真,孙华,李峰.人工胶体液对感染性休克犬血管通透性及血管内皮细胞生长因子的影响[J].中国危重病急救医学,2007,19(5):270-273. 被引量:12
  • 4俞森洋.危重病监护治疗学.北京:北京医科大学、中国协和医科大学联合出版社,1998:67.
  • 5Schatteman GC,Dunnwald M,Jiao C.Biology of bone marrow-derived endothelial cell precursors.Am J Physiol Heart Circ Physiol,2007,292:H1-18.
  • 6Mantovani A,Bussolino F,Introna M.Cytokine regulation of endothelial cell function:from molecular level to the bedside.Immunol Today,1997,18:231-240.
  • 7Combes V,Simon AC,Grau GE,et al.In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.J Clin Invest,1999,104:93-102.
  • 8Moldenhauer A,Nociari M,Lam G,et al.Tumor necrosis factor alpha-stimulated endothelium:an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.Stem Cells,2004,22:144-157.
  • 9Shaffer RG,Greene S,Arshi A,et al.Flow cytometric measurement of circulating endothelial cells:the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.Cytometry B Clin Cytom,2006,70:56-62.
  • 10Vapaatalo H,Mervaala E.Clinically important factors influencing endothelial function.Med Sci Monit,2001,7:1075-1085.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部